Articles tagged "Kidney transplantation"

2021 American Transplant Congress
Identifying the Needs of Kidney Transplant Recipients That Can be Addressed by a Web-based Self-management Program
D. Massierer¹, R. Sapir-Pichhadze², V. Bouchard³, K. Dasgupta², N. Fernandez⁴, D. da Costa², S. Ahmed¹, M. Fortin⁵, R. Langevin⁶, N. Mayo¹, T. Janaudis-Ferreira¹
¹Faculty of Medicine- School of Physical and Occupational Therapy, McGill University, Montreal, QC, Canada, ²Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC, Canada, ³CIUSSS du Saguenay-Lac-Saint-Jean, Chicoutimi, QC, Canada, ⁴Department of Family Medicine/Emergency Medicine, Université de Montreal, Montreal, QC, Canada, ⁵Department of Medicine, Université de Montreal, Montreal, QC, Canada, ⁶Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AB, Canada
*Purpose: Kidney transplantation improves the quality of life (QoL) of patients with end-stage renal disease, however, post-transplant recovery of physical health and other aspects of…
2021 American Transplant Congress
Sodium Zirconium Cyclosilicate Use in Kidney Transplant Recipients
K. J. Swanson, F. Aziz, S. Parajuli, M. Mohamed, D. A. Mandelbrot, A. Djamali, N. Garg
University of Wisconsin-Madison, Madison, WI
*Purpose: Hyperkalemia is a common problem experienced by kidney transplant recipients (KTR)s. New strategies to treat hyperkalemia are now available. KTRs often require medications that…
2021 American Transplant Congress
Tolerability of De Novo and Conversion Belatacept Regimens in Kidney Transplantation
T. Le¹, J. Shoji², J. Phillips¹, D. Quan¹
¹Pharmaceutical Services, UCSF Medical Center, San Francisco, CA, ²Transplant Nephrology, UCSF Medical Center, San Francisco, CA
*Purpose: Belatacept, a selective T lymphocyte co-stimulation blocker, has been shown to be a safe and effective maintenance therapy for immunosuppression. We investigated the long-term…
2021 American Transplant Congress
Graft Volume Changed in the First Year After Living Donor Kidney Transplantation
M. Abou Zeinab, M. Eltemamy, Y. Lin, K. Sasaki, V. Krishnamurthi, Z. Zaky, A. Wee, J. Kaouk
Cleveland Clinic, Cleveland, OH
*Purpose: Pre-donation total kidney volume was shown to correlate with graft outcomes and long-term graft survival. However, only a few studies have studied the changes…
2021 American Transplant Congress
Kidney Transplantation from Marginal Donors: An Increased Risk of Urinary Complication. Study from 10279 Patients
B. Mesnard¹, M. Leroy², J. Hunter³, D. Kervella¹, M. Timsit⁴, L. Badet⁵, P. Glemain¹, E. Morelon⁵, F. Buron⁵, M. Le Quintrec-Donnette⁶, V. Pernin⁶, M. Ladriere⁷, S. Girerd⁷, C. Legendre⁴, A. Sicard⁸, L. Albano⁸, S. De Vergie¹, C. Kerleau¹, T. Prudhomme⁹, J. Rigaud¹, D. Cantarovich¹, G. Blanchot¹, G. Karam¹, M. Giral¹, S. Ville¹, J. Branchereau¹
¹Department of Urology, Chu Nantes, Nantes Université, ITUN, Nantes, France, Nantes, France, ²Department of Urology, Chu Nantes, Nantes Université, France, Nantes, France, ³Department of Urology, Nuffield Department of Surgical Science ,Oxford, Oxford, United Kingdom, ⁴Service de transplantation rénale, Hôpital Necker AP-HP, Paris, France, ⁵Service de transplantation, néphrologie et immunologie clinique, Hôpital Edouard Herriot, Hospices de Lyon, Lyon, France, ⁶Service de néphrologie-soins intensifs-dialyse et transplantation, Hôpital Lapeyronie, Montpellier, France, ⁷Service de transplantation rénale, CHU Brabois, Nancy, France, ⁸Service de néphrologie, Hôpital Pasteur, Nice, France, ⁹Service urologie, andrologie et transplantation rénale, Hôpital Rangeuil, CHU de Toulouse, Toulouse, France
*Purpose: Due to the increasing need of kidneys suitable for transplantation, we have expanded the donor population to include marginal donors (Extended criteria donor, controlled…
2021 American Transplant Congress
Kidney Allograft Outcomes in Pediatric Patients Transitioned to Adult Care – A Single Center Study
S. Subramanyam, G. Agarwal, M. Seifert, V. Kumar, G. Towns, K. Wille, S. Ong
University of Alabama at Birmingham, Birmingham, AL
*Purpose: The transition of healthcare for young adults with kidney transplants from pediatric to adult care settings is an area of need, hitherto under-recognized in…
2021 American Transplant Congress
Psmp is Discriminative for Chronic Active Antibody-Mediated Rejection and Predicts Graft Risk After Kidney Transplantation
Y. Fu, P. Zhan
Tianjin First Central Hospital, Tianjin, China
*Purpose: Chronic active antibody-mediated rejection (c-aABMR) is an intermediate process in the development of chronic antibody-mediated rejection (c-ABMR), a key problem in the long-term failure…
2021 American Transplant Congress
An Early Look at the OPTN Kidney Paired Donation Pilot Program’s New Priority Points Policy
S. E. Booker¹, R. Leishman¹, D. E. Stewart¹, T. Sandholm², J. Dickerson³, M. Pavlakis⁴, V. Casingal⁵
¹United Network for Organ Sharing, Richmond, VA, ²Carnegie Mellon University, Pittsburgh, PA, ³University of Maryland, College Park, MD, ⁴Beth Israel Deaconess Medical Center, Boston, MA, ⁵Carolinas Medical Center, Charlotte, NC
*Purpose: The OPTN implemented new policy on 10/24/19 changing how Kidney Paired Donation Pilot Program (KPDPP) priority points are awarded. The policy is intended to…
2021 American Transplant Congress
Dialysis Staff-Reported Impact of the Early Covid-19 Pandemic on Kidney Transplant Referrals and Evaluations
A. Perez¹, S. Retzloff¹, T. Browne², A. Cruz³, S. Wright³, S. Pastan⁴, R. Patzer¹
¹Department of Surgery, Emory University School of Medicine, Atlanta, GA, ²College of Social Work, University of South Carolina, Columbia, SC, ³IPRO ESRD Network of the South Atlantic, Morrisville, NC, ⁴Department of Medicine, Emory University School of Medicine, Atlanta, GA
*Purpose: COVID-19 has drastically impacted healthcare systems since its declaration as a pandemic in March 2020. Evidence of this impact persists among solid organ transplant…
2021 American Transplant Congress
Characterization of SGLT2 Inhibitor Use After Abdominal Transplant
F. Hailemariam¹, S. Yeager², J. Schulte³, P. Singh¹, A. Yadav¹
¹Transplant Nephrology, Thomas Jefferson University Hospital, Philadelphia, PA, ²Abdominal Transplant Pharmacist, Thomas Jefferson University Hospital, Philadelphia, PA, ³Abdominal Transplant, Clinical Pharmacist, Thomas Jefferson University Hospital, Philadelphia, PA
*Purpose: Post solid organ transplantation, diabetic kidney disease (DKD) can progress due to recurrent pre-transplantation diabetes or the development of post-transplantation diabetes mellitus (PTDM). This…